Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide efficacy and safety on pain in patients with multiple sclerosis
IRCT20190804044429N8Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lacosamide in multiple sclerosis (MS) (2 arms), sponsored by Mazandaran University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
lacosamide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20190804044429N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190804044429N8.